Closure vs Non Closure of Rectus Muscle at Cesarean Section 5 Year Study
Intraperitoneal Adhesions After Rectus Muscles Approximation Clinical Trial
Official title: Closure vs Non Closure of Rectus Muscle at Cesarean Section Reducing Post Cesarean Adhesions
Clinical Trial Summary
approximation of both recti during lower segment cesarean section may be an important step to
lower incidence of intraabdominal adhesions . peritoneal adhesions are of major medical
importance and are associated with clinical problems such as chronic pain and infertility.
Clinical Trial Description
all patients included in the study should be had the operative history of the previous
cesarean section and were done in the cairo university and divid them into 2 groups. 1st
group were both recti approximated while the second group were closed without approximating
both recti. all patients will be subjected to lower segment cesarean segment to assess the
intraperitoneal adhesions, mean operative time, mean hospital stay, postoperative distension,
bowel sounds, postoperative infections and morbidity
Related Conditions & MeSH terms
Intraperitoneal Adhesions After Rectus Muscles Approximation
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.